Trading a CGON straddle lets you take a pure volatility position on Cg Oncology Inc without committing to a direction. Cg Oncology Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate CGON straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on CGON profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Cg Oncology Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the CGON straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Their product candidate cretostimogene, is initially in clinical development for the treatment of patients with high-risk Non-Muscle Invasive Bladder Cancer who are unresponsive to Bacillus Calmette Guerin (BCG) therapy, the current standard-of-care for high-risk NMIBC.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the CGON straddle is the cleanest expression of that view. Our scanner prices every CGON straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a CGON straddle into a catalyst or short a CGON straddle to harvest decay, the options straddle setups that matter are all in one place.
